According to FutureWise analysis the market for Veno–Venous Extracorporeal Life Support (VV ECLS) Devices in 2023 is US$ 0.23 billion, and is expected to reach US$ 0.35 billion by 2031 at a CAGR of 5.20%.
As Veno–venous Extracorporeal Life Support (VV ECLS) continues to evolve, the experience with cannula placement also continues to evolve. Veno-venous Extracorporeal Life Support (VV ECLS) devices are classified as Veno-venous Double Lumen (VVDL), Single Lumen, and other types of cannula in single ventricle patients. According to the location of application, Veno–venous extracorporeal life support (VV ECLS) devices fall into four categories: right atrium, jugular vein, and other veins. The Veno-venous extracorporeal life support (VV ECLS) device has reported effective results in the jugular vein and right atrium.
Veno-venous Extracorporeal Life Support (VV ECLS) Devices have been reported to be used both in single-ventricle and biventricular patients. However, due to the reported effectiveness of VV ECLS devices on single-ventricle patients, there has been an increase in the number of devices available in the market.
The demand for Veno-venous Extracorporeal Life Support (VV ECLS) devices is on the rise with the increasing incidences of cardiopulmonary disease and respiratory failure disorders. Veno-venous extracorporeal life support (VV ECLS) has shown promising results in pediatric and neonatal patients suffering from acute respiratory distress syndrome (ARDS) or single-ventricle physiology. For cardiopulmonary disease treatment, it has shown better results than venoarterial ECLS. NCBI (2016) reports that Veno-venous Extracorporeal Life Support (VV ECLS) offers a survival rate of about 48%, which is comparable to the survival rate of venoarterial ECLS at 32%. In patients with single-ventricle disorders, both arterial and venous thrombi are a substantial risk because the coronary, pulmonary and cerebral circulations are vulnerable.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Veno–Venous Extracorporeal Life Support (VV ECLS) Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Veno–Venous Extracorporeal Life Support (VV ECLS) Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.